Home NDC 50090-5829-0 Acarbose
Product NDC 50090-5829
Requested package NDC 50090-5829-0
11-digit product format 500905829
Labeler code 50090
Product ID 50090-5829_49410201-806b-4f8b-9638-24f91d5ae72b
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name acarbose
Dosage form TABLET
Route ORAL
Labeler A-S Medication Solutions
Application ANDA090912
Marketing category ANDA
Marketing start 2016-12-10
Marketing end 0000-00-00
Substance ACARBOSE
Active strength 100 mg/1
Pharmacologic classes alpha Glucosidase Inhibitors [MoA],alpha-Glucosidase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 15 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A090912-001 ACARBOSE ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 A090912-002 ACARBOSE ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 A090912-003 ACARBOSE ACARBOSE 100MG TABLET / ORAL AB 2011-07-27
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 3 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090912-002 ACARBOSE 50MG TABLET / ORAL AB 2011-07-27 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A090912-003 ACARBOSE 100MG TABLET / ORAL AB 2011-07-27 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A090912-001 ACARBOSE 25MG TABLET / ORAL AB RS 2011-07-27 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 123 observed states.
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50090-5829-0 Acarbose 30 in 1 BOTTLE TABLET 30 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50090-5829 ACARBOSE TABLET [A-S MEDICATION SOLUTIONS] 1 Legacy NDC, 1 package rows 20211030_bf8500e1-9037-43f5-855b-d336d92d5cb7.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50090-5829-0 50090582900 30 TABLET in 1 BOTTLE (50090-5829-0) 30 tablet 2021-10-26 0000-00-00 No No Current